Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Protective role of muscones on astrocytes under a mechanical-chemical damage model

Protective role of muscones on astrocytes under a mechanical-chemical damage model

Ann Transl Med, 2022 · DOI: 10.21037/atm-22-3848 · Published: September 1, 2022

Spinal Cord InjuryPharmacologyNeurology

Simple Explanation

Traumatic spinal cord injury (SCI) is a major clinical concern with substantial socioeconomic implications. The initial mechanical force applied to the spinal cord is known as the primary injury. After the primary injury, ischemia and hypoxia induce cell death and autolysis, which are associated with the release of inflammatory factors. These processes are called the secondary injury, and may lead to an excess of extracellular glutamate (Glu), which in turn promotes the neuronal injuries. Muscone has been shown to have anti-inflammatory effects in the treatment of brain diseases and other diseases. Astrocytes were separated and purified, and a mechanical-chemical damage (MCD) model was established via the primary spinal astrocytes of rats, and treatment was administered with different concentrations of muscone. Muscone reduced the levels of LDH, TNF-α, and MDA after injury, and upregulated the level of SOD. Muscone also reduced the density of extracellular Glu and suppressed the intracellular calcium level. Additionally, it decreased the expression levels of EAATs and GFAPs. Muscone has a protective effect on astrocytes in a MCD and inhibits astrocytes’ proliferation.

Study Duration
Not specified
Participants
Primary spinal astrocytes of rats
Evidence Level
Not specified

Key Findings

  • 1
    Muscone reduced the levels of LDH, TNF-α, and MDA after injury, and upregulated the level of SOD.
  • 2
    Muscone also reduced the density of extracellular Glu and suppressed the intracellular calcium level.
  • 3
    Additionally, it decreased the expression levels of EAATs and GFAPs.

Research Summary

Muscone has a protective effect on astrocytes in a MCD and inhibits astrocytes’ proliferation. Muscone is a significant biomarker for SCI treatment and does not have the side-effects of glucocorticoids. It has an anti-inflammatory ability, reduces calcium influx, protects astrocytes from further damage and increases cell viability after damage. It also reduces intercellular Glu, which may protect neurons from damage by toxic neurotransmitters.

Practical Implications

Therapeutic Potential

Muscone may be a potential therapeutic agent for treating spinal cord injuries by protecting astrocytes and reducing inflammation.

Alternative to Glucocorticoids

Muscone could serve as an alternative to glucocorticoids in SCI treatment, avoiding the side effects associated with glucocorticoids.

Mechanism Clarification

Further research is needed to elucidate the exact mechanisms by which muscone exerts its protective effects on astrocytes and its influence on glutamate recycling.

Study Limitations

  • 1
    The study uses an in vitro model, which may not fully replicate the complex in vivo environment of spinal cord injury.
  • 2
    The study focuses on astrocytes; the effects of muscone on other cell types involved in SCI, such as neurons and immune cells, need to be further investigated.
  • 3
    The precise mechanisms by which muscone reduces intercellular Glu concentration and suppresses EAAT activation and astrocyte proliferation remain unclear.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury